Focused CRISPR-Cas9 Genetic Screening Reveals USO1 as a Vulnerability in B-Cell Acute Lymphoblastic Leukemia

CRISPR/Cas9-mediated disruption of USO1 in MLL-translocated B-cell acute lymphoblastic leukemia cells reduced cell growth, promoted cell death, and altered the cell cycle.